DDMAC's "Bad Ad" Enforcement Often Requires Affidavits
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Division of Drug Marketing, Advertising and Communications is preparing several enforcement letters triggered by complaints from doctors.